Effective treatments fo r the common cold have been diffic ult to develop because so many different types of virus are respons ible for this condition. Oral zinc has been studied as a possible mea ns ofpreventing O I' alle viating symptotns, with mixed resu lts. We studied a new app roach to zinc therapy-an ever-the -cou nter nasal ge l formu lation (Zieam) -to independently eva luate its efficaey as a treatment fo r the common cold. Our study was conducted at [o ur sites ove r a 5-month pe riod. The study group cons isted of2 13 patients with recent-onset ("5,24 hr) cold symptoms; 108 patients received zlnc therapy, and 105 received placebo. Sytnptom cha rts we re used to track the duration and severity ofeach patient's symptoms. At study 's end, the duration ofsymptoms was 2.3 days (± O. 9) in the zinc gro up and 9.0 days (±2.5) in the control gro up-s-a statistically significant differenee (p <0. 05). These results provide evidence tha t zinc nasal gel is effective in sho rtening the duration of common cold symptoms when tak en within 24 hou rs of their onse t.
Introduction
The common cold is ca used by a viral infection in the nose.' Its symptoms, which vary in severity, include sneezing,rhinorrhea, nasal congestion, sore and/or scratchy throat, cough, hoarseness, and mild ge nera l sympto ms such as headache, fever, and body aches. '-' Of the more than 100 differe nt co ld viruses, the most important are rhinov iruses.' Th e lack of effective treatments for the co mmon cold is of co ncern because aduits contrac t an average of approxi mate ly three col ds eac h year , and children experience twice as many. 2 The number of work days lost to co ld-related illness is substan tial.' From 
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The use of zinc formulations for the treatm ent of common cold symptoms has been receiving increasing attention in the medi cal literature as weil as in the lay press. Some studies in hum ans have show n that zinc lozenges were effec tive in shor teni ng the duration of co mmon co ld symptoms in adults.>? There have also been some negative reports coneerning the use ofzine lozenges, but these findings appear to be rela ted to the use of formu lations that did not allow the release of ionized zinc into the ora l cav ity.!? It has been show n that ionized zinc has direet antirhinoviral act ivity .t''!' protects ce lls fro m dam age by viral toxins," and migh t inhibit the rhin ovirus' ability to attac h to, enter, and infect hum an nasal ce lls."
Recentl y, a new approac h to zinc therapy-an ove rthe-co unter nasal ge l formulation (Zieam)-was the subject of a preliminary study (C.B. Hensley, PhD , and R. Davidson, PhD, unpublished data, 1999) . That study demonstrated that the direet application of the nasal gel co ntaining 33 mmol/L of ionic zinc within 24 hour s of the onset of co mmon cold symptoms sig nificantly shortened the duration of those sy mptoms. The researchers hypothesized that the delivery of ionic zinc directly to the site of infection should be more effec tive tha n oral delivery.
Th e goa l of our study was to atte mpt to reprod uee those resuits and independentl y assess the effect of zinc nasal ge l on the duration of commo n co ld symptoms .
M aterials and methods
Our methodology was simi lar to that used by Mossad et al in their clinica l ev aluation of zinc lozenges in 1996. 7 Subjec ts were rec ru ited at four sites in the Los Angeles area . The study popu lation co nsisted of2 13 subjects; they were rando mly ass igned to receive either zine nasa l ge l (n = 108) or placeb o (n = 105). Onl y subjec ts whose co ld symptoms had been mani fest for 24 hours or less were enrolled in the study. Subje ets were required to have had at least three of the foll owing symptoms: co ugh, headache, hoarsene ss, muscle ache, nasal drainage, nasal con- data, 1999). Although zinc nasal gel ' s precise mec hanism of action has yet to be elucidated, data suggest that ionic zinc has a direet effect on the ability of rhinovirus to infect and/or reinfect the nasal epithelium. IO , l l Zinc ions form complexes with rhinovirus coat proteins. This interaction causes an irreversible alteration in the coat proteins and interferes with the assembly mechanism of the virus particles. " In addition, Novick et al reported that ion ized zinc can directly inhibit the rhinovirus' ability to attach to, enter, and infect human nasal cells." The crystalographically modeled surface features of human rhinovirus-14 provide binding sites for approximately 360 zinc ions . The binding of ionic zinc is stab ilized by histidine, methionine, tyros ine, and carboxyl/carboxylate gro ups that line the rhinovirus-14 surfaee canyons. It has been proposed that this interaction blocks the rhinovirus' ability to dock with intercellular adhesion moleeule binding sites.
In concl usion, our results support the findings of the 
ca e,
Results
The duration of each patient's cold was defined as the number of days from study entry to the complete resolution of symptoms. The zine nasal gel had a significant effeet in shortening their duration (figure I) . The mean resolution time was 2.3 days (±0 .9) for the zinc patients and 9.0 days (±2.5) for the controis (figure 2). The differenee was statistically significant (p<0.05). Subjects had also been provided a list of five potential side effeets (nausea, bad taste reactions, odor, dizziness, and drowsiness) and asked during the study and again at the end of the study whether they had experienced these or any others. While none of the subjects reported any of these five side effects, 45 zinc patients (42%) and 39 controis (37%) did report that they had experienced a slight tingling or burning sensation.
Discussion
The 75% difference in the duration of symptoms in our study is consistent with the 85% reduction reported by C.B. Hensley, PhD, and R. Davidson, PhD (unpublished gestion, scratchy throat, sore throat, or sneezingo All participants provided infonned consent upon enrollment. Exc1usion criteria were pregnancy, an immunocompromised state, a duration of common cold symptoms beyond 24 hours, and the use of certain medications.
The zinc nasal gel consisted of zinc gluconate in an emu lsion of benzalkonium chloride, glycerin, hydroxyethyleellulose, sodium chloride, and sodi um hydroxide; its pH level was 7.2. The eomposition of the placebo gel was identical except that it did not con tain zine.
Both gels were dispensed in a double-blind fashion in metered doses of 120 III in applicators supplied by Botanical Laboratories (Ferndale, Wash.) . Subjects were instructed to sprayone dose into each nostril every 4 hours (9 a.m. , I p.m. , 5 p.m. , and 9 p.m .) for as long as they experienced symptoms. Participants were instructed not to take any other cold remedies or any drugs that might affect symptom scores.
Patients were provided with a diary to document the severity of their symptoms. Twice eac h day (at 9 a.m. and 9 p.m.), patients graded each of nine symptoms on a sca le of 0 (absent) to 3 (severe). The tota l daily symptom scores were added toge ther, and the mean and standard deviations were cale ulated for each patient.
The primary endpoint was the eomplete resolution of symptoms, which was determined when the total syrnptom score fell to zero . Subjects were asked to return to their study site within 24 hours of symptom resolution for verification and followup . 
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